Neurotech International Limited (NTI.AX)
AUD 0.03
(13.04%)
AUD 0.03
(13.04%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -5.58 Million AUD | 38.07% |
| 2023 | -9.01 Million AUD | -130.06% |
| 2022 | -3.92 Million AUD | 47.35% |
| 2021 | -7.44 Million AUD | -486.28% |
| 2020 | -1.26 Million AUD | 52.31% |
| 2019 | -2.66 Million AUD | 28.98% |
| 2018 | -3.74 Million AUD | 3.66% |
| 2017 | -3.89 Million AUD | -117.81% |
| 2016 | -1.78 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | -7.08 Million AUD | 0.0% |
| 2024 Q2 | -3.93 Million AUD | 0.0% |
| 2024 FY | -8.76 Million AUD | 2.86% |
| 2023 FY | -9.01 Million AUD | -130.06% |
| 2023 Q2 | -4.72 Million AUD | 0.0% |
| 2023 Q4 | -4.29 Million AUD | 0.0% |
| 2022 Q2 | -1.94 Million AUD | 0.0% |
| 2022 FY | -3.92 Million AUD | 47.35% |
| 2022 Q4 | -1.55 Million AUD | 0.0% |
| 2021 FY | -7.44 Million AUD | -486.28% |
| 2021 Q4 | -3.82 Million AUD | 0.0% |
| 2021 Q2 | -3.62 Million AUD | 0.0% |
| 2020 Q4 | -568.55 Thousand AUD | 0.0% |
| 2020 FY | -1.26 Million AUD | 52.31% |
| 2020 Q2 | -701.37 Thousand AUD | 0.0% |
| 2019 Q2 | -1.57 Million AUD | 0.0% |
| 2019 Q4 | -1.43 Million AUD | 0.0% |
| 2019 FY | -2.66 Million AUD | 28.98% |
| 2018 Q4 | -1.95 Million AUD | 0.0% |
| 2018 FY | -3.74 Million AUD | 3.66% |
| 2018 Q2 | -1.79 Million AUD | 0.0% |
| 2017 Q4 | -1.79 Million AUD | 0.0% |
| 2017 Q2 | -2.09 Million AUD | 0.0% |
| 2017 FY | -3.89 Million AUD | -117.81% |
| 2016 Q2 | -587.83 Thousand AUD | -100.0% |
| 2016 Q1 | -293.91 Thousand AUD | 0.0% |
| 2016 Q3 | - AUD | 100.0% |
| 2016 FY | -1.78 Million AUD | 0.0% |
| 2016 Q4 | -1.81 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 80.03% |
| Adherium Limited | -11.98 Million AUD | 53.403% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 42.941% |
| Atomo Diagnostics Limited | -4.36 Million AUD | -28.048% |
| Anteris Technologies Ltd | -66.63 Million AUD | 91.619% |
| Control Bionics Limited | -5.92 Million AUD | 5.81% |
| CardieX Limited | -4.63 Million AUD | -20.525% |
| Compumedics Limited | -269 Thousand AUD | -1976.132% |
| Cochlear Limited | 521.5 Million AUD | 101.071% |
| CleanSpace Holdings Limited | -4.81 Million AUD | -16.012% |
| Cyclopharm Limited | -9.22 Million AUD | 39.458% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -245.934% |
| Nova Eye Medical Limited | -3.79 Million AUD | -47.084% |
| HeraMED Limited | -6.42 Million AUD | 13.118% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 68.224% |
| ImpediMed Limited | -19.03 Million AUD | 70.662% |
| InhaleRx Limited | -1.38 Million AUD | -302.802% |
| LBT Innovations Limited | -4.74 Million AUD | -17.823% |
| Micro-X Limited | -13.02 Million AUD | 57.129% |
| OncoSil Medical Limited | -11.98 Million AUD | 53.399% |
| PolyNovo Limited | 1.16 Million AUD | 580.206% |
| Respiri Limited | -7 Million AUD | 20.22% |
| SomnoMed Limited | -3.84 Million AUD | -45.388% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 66.519% |
| Uscom Limited | -2.4 Million AUD | -132.279% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | 4.601% |